Vagitab-T + metronidazole

Vagitab-T + metronidazole is a **combination therapy** consisting of a vaginal tablet (likely referenced as Vagitab-T, although insufficient detail is available about its individual composition) and metronidazole. Metronidazole is a nitroimidazole antibiotic effective against anaerobic bacteria and protozoa, particularly for treating trichomoniasis and bacterial vaginosis. In clinical studies, combinations like metronidazole vaginal effervescent tablets with another local agent (e.g., matrine suppository, which is a form of Sophora flavescens, but not Vagitab-T) have shown enhanced efficacy over metronidazole alone for trichomonas vaginitis, resulting in greater reduction in inflammation, improved restoration of vaginal pH, and lower recurrence rates. Metronidazole works by generating cytotoxic free radicals that disrupt DNA in anaerobic microorganisms, leading to cell death[1][3][4]. The combination is intended to increase clinical effectiveness for vaginal infections, particularly trichomoniasis, and possibly other mixed vaginitis indications.

Brand names

Vagitab-T + metronidazole

Other names

Vagitab-T + metronidazole